Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2012
10/17/2012EP2509594A1 Endothelin inhibitors for the treatment of rapidly progressive glomerulonephritis
10/17/2012EP2509593A2 Therapeutic use of protein-polymer conjugates
10/17/2012EP2509592A1 Bibw 2992 for use in the treatment of triple negative breast cancer
10/17/2012EP2509591A1 Methods and compositions for treating disease or condition related to orexin receptor 1, orexin receptor 2, somatostatin receptor 2 or dopamine d2l receptor
10/17/2012EP2509590A1 Histone acetyltransferase activators and uses thereof
10/17/2012EP2509589A1 Pharmaceutical or veterinary antiviral compositions
10/17/2012EP2509586A1 Mucoadhesive buccal tablets for the treatment of orofacial herpes
10/17/2012EP2509585A1 Process and product
10/17/2012EP2509584A1 Pharmaceutical composition for treating cutaneous burns
10/17/2012EP2509582A1 Stable aqueous compositions of prostglandin agonist prodrugs and methods for use thereof
10/17/2012EP2509452A2 Low caloric fat replacers
10/17/2012EP2509436A1 Carnitine granulate and methods for its production
10/17/2012EP2509424A1 Novel oxadiazole compounds
10/17/2012EP2509421A1 Drug delivery of temozolomide for systemic based treatment of cancer
10/17/2012EP2509418A1 Methods and low dose regimens for treating red blood cell disorders
10/17/2012EP2509414A1 Micro-colloidal silicic acid / boric acid composition and a method of preparing a bioenhancing solution and powder
10/17/2012EP1631255B1 Drug delivery system
10/17/2012CN1948274B Verakanol derivative, preparation method and use thereof
10/17/2012CN1927183B Antineoplasma medicine pidorubicin slow release microsphere preparation and method for preparing same
10/17/2012CN1922171B Pyrimidine derivative
10/17/2012CN1823092B Therapy-enhancing glucan
10/17/2012CN1763057B Nucleotide analog compound
10/17/2012CN1684701B Ophthalmologic irrigation solutions and method
10/17/2012CN102741396A Small molecules supporting pluripotent cell growth and methods thereof
10/17/2012CN102741296A Branched soluble glucose polymers for peritoneal dialysis
10/17/2012CN102741270A Cyclic peptide inhibitors of hepatitis c virus replication
10/17/2012CN102741268A Pyrrolidine derivatives
10/17/2012CN102741264A Prostate specific membrane antigen inhibitors
10/17/2012CN102741262A Pharmaceutical composition containing cyclometalated n-heterocyclic carbene complexes for cancer treatment
10/17/2012CN102741261A New aminoacid derivatives, their process of preparation and their therapeutical uses as inhibitors of oncogenic signals by the met family
10/17/2012CN102741260A New maytansinoids and the use of said maytansinoids to prepare conjugates with an antibody
10/17/2012CN102741259A Nitroimidazooxazine and nitroimidazooxazole analogues and their uses
10/17/2012CN102741258A Compositions and methods for cyclofructans as separation agents
10/17/2012CN102741257A Spiroindolinone pyrrolidines
10/17/2012CN102741256A Bicyclic heteroaryl derivatives having inhibitory activity for protein kinase
10/17/2012CN102741255A Antimalarial agents that are inhibitors of dihydroorotate dehydrogenase
10/17/2012CN102741253A Pi3k (delta) selective inhibitors
10/17/2012CN102741252A Spiroindoline compounds for use as anthelminthics
10/17/2012CN102741250A Heteroaromatic phenylimidazole derivatives as PDE10A enzyme inhibitors
10/17/2012CN102741249A Hetaryl-[1,8]naphthyridine derivatives
10/17/2012CN102741248A Novel (heterocycle/condensed piperidine)-(piperazinyl)-1-alcanone or (heterocycle/condensed pyrrolidine)-(piperazinyl)-1-alcanone derivatives, and use thereof as p75 inhibitors
10/17/2012CN102741247A Anti parasitic dihydroazole compounds and compositions comprising same
10/17/2012CN102741246A Novel polymorphic shapes of methyl{4,6-diamino-2-[1-(2-fluorobenzyl)-1h-pyrazolo[3,4-b]pyridine-3-yl]pyrimidin-5-yl)carbamate
10/17/2012CN102741245A Benzoimidazole compounds and uses thereof
10/17/2012CN102741243A Novel compound amycolatopsis derivative, and production process and use of same
10/17/2012CN102741241A Benzimidazole-imidazole derivatives
10/17/2012CN102741240A Pyrimidine compounds as delta opioid receptor modulators
10/17/2012CN102741239A Bicyclic compounds as alpha4beta2 nicotinic acetylcholine receptor ligands
10/17/2012CN102741234A Polymorphic, crystalline and mesophase forms of sodium 2-(5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4h-1,2,4-triazol-3-ylthio)acetate, and uses thereof
10/17/2012CN102741232A Condensed ring pyridine compounds as subtype-selective modulators of sphingosine-1-phosphate-2 (s1p2) receptors
10/17/2012CN102741228A 4- (azacycloalkyl) -benzene-1, 3 -diol derivatives as tyrosinase inhibitors and their synthesis and use thereof
10/17/2012CN102741227A Aryl benzylamine compounds
10/17/2012CN102741226A 4-substituted-2-phenoxy-phenylamine delta opioid receptor modulators
10/17/2012CN102741220A New aminotetraline derivatives
10/17/2012CN102740920A System for treating target tissue within the eustachian tube
10/17/2012CN102740895A Nanoconjugates and nanoconjugate formulations
10/17/2012CN102740894A Sdf-1 delivery for treating ischemic tissue
10/17/2012CN102740890A Transdermal preparation containing basic anti-inflammatory agent
10/17/2012CN102740886A Use of vap-1 inhibitors for treating fibrotic conditions
10/17/2012CN102740875A Nanoparticle carrier systems based on human serum albumin for photodynamic therapy
10/17/2012CN102740863A Copper salts of ion exchange materials for use in the treatment and prevention of infections
10/17/2012CN102740862A Microspheres of hydrolysed starch with endogenous, charged ligands
10/17/2012CN102740861A Compositions and methods for treating hepatitis b virus infection
10/17/2012CN102740860A Read through inducer, and therapeutic agent for nonsense-mutation-type genetic diseases
10/17/2012CN102740859A Method for removing cytokines from blood with surface immobilized polysaccharides
10/17/2012CN102740858A Pharmaceutical composition having antimicrobial and anti-inflammatory activity for parenteral administration, process for preparing same
10/17/2012CN102740857A Complex formulation comprising aspirin coated with barrier containing hydrophobic additive, and hmg-coa reductase inhibitor
10/17/2012CN102740856A Crystalline forms of neurotrophin mimetic compounds and their salts
10/17/2012CN102740855A Extended release preparation
10/17/2012CN102740854A Loxoprofen-containing pharmaceutical composition
10/17/2012CN102740853A Drug combination with theobromine and its use in therapy
10/17/2012CN102740852A N-substituted deoxynojirimycin compounds for use in inhibiting osteoclastogenesis and/or osteoclast activation
10/17/2012CN102740851A Combinations of a PI3K inhibitor and a MEK inhibitor
10/17/2012CN102740849A Dual-action compounds targeting adenosine a2a receptor and adenosine transporter for prevention and treatment of neurodegenerative diseases
10/17/2012CN102740848A Tetrahydro-pyran derivatives against neurological illnesses
10/17/2012CN102740847A Heteroaryl compounds and uses thereof
10/17/2012CN102740846A Compositions for topical administration
10/17/2012CN102740845A Treatment of microbial infections
10/17/2012CN102740844A Combination of droloxifene and clopidogrel
10/17/2012CN102740843A Combination of theobromine with a decongestant and its use for the treatment of cough
10/17/2012CN102740842A Formulations, salts and polymorphs of transnorsertraline and uses thereof
10/17/2012CN102740841A Solid dispersions containing 20-O-beta-D-glucopyranosyl-20(S)-protopanaxadiol
10/17/2012CN102740839A Immediate release tablet formulations
10/17/2012CN102740836A Method for the production of commercial nanoparticle and microparticle powders
10/17/2012CN102740834A Polymer nanoparticle injection formulation composition containing rapamycin with improved water solubility, preparation method thereof, and anticancer composition for combined use with radiotherapy
10/17/2012CN102740833A Parenteral formulations of gemcitabine derivatives
10/17/2012CN102740831A Pharmaceutical composition with anti-obesity activity comprising a premixture of pure orlistat and preparation process
10/17/2012CN102740830A Sustained release delivery devices
10/17/2012CN102740714A Method for treatment of lacto-n-biose-containing solution
10/17/2012CN102740713A High fiber nutritional emulsions for blood glucose control
10/17/2012CN102740712A Low caloric fat replacers
10/17/2012CN102740706A Compositions including pyruvate for companion animals and methods of use thereof
10/17/2012CN102740698A Compounds and methods for kinase modulation, and indications therefor
10/17/2012CN102740695A Composition for control of animal parasites, and method for control of animal parasites
10/17/2012CN102740693A Compounds for treating disorders or diseases associated with neurokinin 2 receptor activity
10/17/2012CN102735806A A method for screening traditional Chinese medicine monomers
10/17/2012CN102733088A Thermo-sensitive poly N-isopropylacrylamide/polyurethane medicine-loading electro-spun fibrous membrane and preparation method thereof
10/17/2012CN102732515A Nucleotide sequence and application thereof
10/17/2012CN102732474A Compound for inhibiting mycobacterium tuberculosis, screening method and uses thereof
10/17/2012CN102731772A Camptothecin compound pegylated derivatives
1 ... 997 998 999 1000 1001 1002 1003 1004 1005 1006 1007 1008 1009 1010 1011 1012 1013 1014 1015 1016 1017 ... 7860